Corestreet Logo

Neurocrine Biosciences Inc (NBIX) Insider Trading

Total insider buys:
  • $39,032,821.44
Total insider sells:
  • $346,242,053.69
Most recent insider trade:
  • Aug. 15, 2024
Most active insider trader:
  • Kevin Charles Gorman
Trader NameDateTitleAmountPriceTypeTotal Value
Sept. 1, 2023Director5,000$110.06Sell$550,300.00
Sept. 1, 2023Insider824$110.93Sell$91,406.32
Aug. 30, 2023Insider2,733$107.60Sell$294,070.80
Aug. 28, 2023Insider1,431$107.52Sell$153,861.12
Aug. 21, 2023CFO2,132$107.39Sell$228,955.48
Aug. 21, 2023CEO9,328$107.40Sell$1,001,827.20
Aug. 21, 2023Insider3,198$107.37Sell$343,369.26
May 1, 2023Director4,300$101.43Sell$436,149.00
May 1, 2023Insider11,397$103.89Sell$1,184,034.33
April 24, 2023Insider14,400$103.48Sell$1,490,112.00
April 21, 2023Director6,034$105.04Sell$633,811.36
April 19, 2023Director903$105.00Sell$94,815.00
Feb. 23, 2023Major Shareholder4,395,588$8.88Buy$39,032,821.44
Feb. 8, 2023CEO2,274$104.30Sell$237,178.20
Feb. 8, 2023Insider980$104.12Sell$102,037.60
Feb. 7, 2023CFO26,328$102.40Sell$2,695,987.20
Feb. 6, 2023CEO3,040$105.68Sell$321,267.20
Feb. 6, 2023Insider1,280$105.63Sell$135,206.40
Jan. 31, 2023CEO2,707$110.08Sell$297,986.56
Jan. 31, 2023Insider1,457$109.99Sell$160,255.43
Jan. 31, 2023CFO1,283$109.98Sell$141,104.34
Jan. 6, 2023Insider400$125.00Sell$50,000.00
Jan. 3, 2023Director30,000$118.86Sell$3,565,800.00
Nov. 30, 2022Insider50,000$125.90Sell$6,295,000.00
Nov. 10, 2022Insider100$125.36Sell$12,536.00
Nov. 8, 2022Insider24,593$125.33Sell$3,082,240.69
Nov. 3, 2022Insider4,518$125.02Sell$564,840.36
Nov. 1, 2022Insider10,000$120.09Sell$1,200,900.00
Oct. 31, 2022Director15,000$114.76Sell$1,721,400.00
Oct. 27, 2022Insider4,923$115.04Sell$566,341.92
Oct. 17, 2022Insider4,960$110.82Sell$549,667.20
Oct. 4, 2022Director5,000$110.54Sell$552,700.00
Oct. 3, 2022Insider1,437$106.59Sell$153,169.83
Aug. 12, 2022Insider21,533$105.95Sell$2,281,421.35
June 27, 2022Insider754$100.00Sell$75,400.00
May 9, 2022Director15,000$76.30Sell$1,144,500.00
April 25, 2022Director15,000$92.76Sell$1,391,400.00
April 1, 2022Director10,728$94.93Sell$1,018,409.04
March 22, 2022Insider8,455$95.05Sell$803,647.75
March 18, 2022Insider300$95.00Sell$28,500.00
Feb. 7, 2022CEO8,710$80.82Sell$703,942.20
Feb. 7, 2022Insider240$81.07Sell$19,456.80
Feb. 7, 2022CFO3,310$80.79Sell$267,414.90
Jan. 24, 2022Director15,000$74.43Sell$1,116,450.00
Jan. 10, 2022Insider2,632$74.50Sell$196,084.00
Jan. 5, 2022Insider28,266$85.50Sell$2,416,743.00
Dec. 1, 2021CFO1,645$82.59Sell$135,860.55
Oct. 7, 2021Director5,000$105.06Sell$525,300.00
Oct. 7, 2021Insider8,000$104.81Sell$838,480.00
Oct. 4, 2021Insider987$101.73Sell$100,407.51
First«2 of 6»Last

  • Insiders are both buying and selling Neurocrine Biosciences Inc stock.

  • The insider traders at Neurocrine Biosciences Inc are: Kevin Charles Gorman, Gary A Lyons, Darin Lippoldt, Haig P Bozigian, Dimitri E Grigoriadis, Christopher Flint Obrien, Matt Abernethy, Eiry Roberts, Eric Benevich, Timothy P Coughlin, Kyle Gano, Malcolm Lloyd-Smith, Julie Cooke, Ingrid Delaet, Richard F Pops, William H Rastetter, David W Boyer, W Thomas Mitchell, Stephen A Sherwin, Timothy Coughlin, Corinne H Nevinny, Jude Onyia, Dimitri Grigoriadis, Haig Bozigian, Dimitri E. Grigoriadis, Shalini Sharp, Leslie V. Norwalk, Gary A. Lyons, George J. Morrow, Haig P. Bozigian, and Neurocrine Biosciences Inc

  • The most active insider trader at Neurocrine Biosciences Inc is Kevin Charles Gorman with 41 trades.

  • Kevin Charles Gorman has sold the most Neurocrine Biosciences Inc stock with a total value of $98,873,670.68.

  • Neurocrine Biosciences Inc has bought the most Neurocrine Biosciences Inc stock with a total value of $78,065,642.88.

  • The most recent insider trade for Neurocrine Biosciences Inc was on Aug. 15, 2024.

  • The single biggest insider buy for Neurocrine Biosciences Inc was from Neurocrine Biosciences Inc with a total value of $39,032,821.44 on Feb. 23, 2023.

  • The single biggest insider sell for Neurocrine Biosciences Inc was from Kevin Charles Gorman with a total value of $33,975,315.00 on Jan. 8, 2021.